Production (Stage)
BioAtla, Inc.
BCAB
$0.3896
$0.00832.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.00M | 11.00M | 11.00M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.00M | 11.00M | 11.00M | -- | -- |
| Cost of Revenue | 56.60M | 63.10M | 74.12M | 86.12M | 100.89M |
| Gross Profit | -45.60M | -52.10M | -63.12M | -86.12M | -100.89M |
| SG&A Expenses | 21.50M | 21.85M | 23.12M | 23.86M | 24.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.10M | 84.94M | 97.24M | 109.99M | 125.21M |
| Operating Income | -67.10M | -73.94M | -86.24M | -109.99M | -125.21M |
| Income Before Tax | -61.88M | -69.78M | -81.82M | -104.56M | -119.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.88 | -69.78 | -81.82 | -104.56 | -119.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.88M | -69.78M | -81.82M | -104.56M | -119.24M |
| EBIT | -67.10M | -73.94M | -86.24M | -109.99M | -125.21M |
| EBITDA | -66.23M | -73.02M | -85.17M | -108.88M | -124.05M |
| EPS Basic | -1.22 | -1.44 | -1.70 | -2.18 | -2.49 |
| Normalized Basic EPS | -0.76 | -0.90 | -1.06 | -1.36 | -1.56 |
| EPS Diluted | -1.22 | -1.44 | -1.70 | -2.18 | -2.49 |
| Normalized Diluted EPS | -0.76 | -0.90 | -1.06 | -1.36 | -1.56 |
| Average Basic Shares Outstanding | 204.45M | 194.29M | 192.63M | 192.13M | 191.62M |
| Average Diluted Shares Outstanding | 204.45M | 194.29M | 192.63M | 192.13M | 191.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |